Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...
Fortrea collaborates with Emery Pharma for rapid rifampin impurity testing in drug-drug interaction studies, enhancing participant safety and data quality. Fortrea, a global contract research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results